How to Read and Trade AI Powered Stock Charts
Enter Stock Symbol to View AI powered Stock Chart
StockChartsAI.com
All Chart Prices as of Previous Day CloseBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
12/07/2023 16:05:00 EST
Iovance Biotherapeutics Inc (IOVA)
Industry: Biotechnology
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 30 trading days, IOVA has been trading in a range between $5.79 and $3.30 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
IOVA is trading between resistance at $7.50 about 11% to the upside and support at $6.27 -7% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $9.06, about a 35% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Iovance Biotherapeutics Inc (IOVA) entered a Green zone 17 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 4.500, which is a Strong Buy. The current analyst target price is $22.36, which gives it a potential upside of 232.24 % from the recent price of 6.73. The stock is trading 39.08% (potential upside) below its 52 week high of $9.36 and 109.66 % (potential downside) above its 52 week low of $3.21 - based on the recent price.
Company Summary
Iovance Biotherapeutics, Inc, a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company's lead product candidate is lifileucel that is in Phase II clinical trial for the treatment of metastatic melanoma and cervical cancer.
News
| Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report? Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? Source: Zacks Investment Research Thu, 07 Dec 2023 12:48:04 -0500 Sentiment: Positive |
| 3 Penny Stocks to Buy to Turn $1 into $100: November 2023 In this market cycle that we are experiencing, new opportunities arise to take advantage of over the next few years. There is no better way to take advantage of these opportunities than through penny stocks. Source: InvestorPlace Wed, 22 Nov 2023 14:22:43 -0500 Sentiment: Neutral |
| Why Iovance Biotherapeutics Stock Is Jumping Today Goldman Sachs initiated a buy recommendation on Iovance with a $12 price target. Many on Wall Street like the stock because of the potential near-term approval of its promising melanoma drug. Source: The Motley Fool Mon, 20 Nov 2023 12:00:21 -0500 Sentiment: Positive |
| Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) SAN CARLOS, Calif., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that on November 16, 2023 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 59,950 shares of Iovance's common stock to nine new non-executive employees. Source: GlobeNewsWire Fri, 17 Nov 2023 17:00:00 -0500 Sentiment: Neutral |
| Why Iovance Biotherapeutics Stock Is Marching Higher Today Biotech stocks are slumping yet again today. However, Iovance Biotherapeutics is swimming against the current thanks to excitement over its adoptive cell therapy. Source: The Motley Fool Wed, 08 Nov 2023 13:03:43 -0500 Sentiment: Positive |
Technicals 52 Week Hi: 9.36 52 Week Low: 3.21 Beta: 0.36 50 Day MA: 4.4546 200 Day MA: 6.2499 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0 Qtr Revenue Growth YOY: 0 Forward PE: 0 Trailing PE: 0